Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 301–400 of 938
Sudarshan, S., Pinto, P. A., Neckers, L., & Linehan, W. M. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0711 · Cited by 65
Model animals for the study of oxidative stress from complex II
Ishii, T., Miyazawa, M., Onouchi, H., Yasuda, K., Hartman, P. S., & Ishii, N. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.016 · Cited by 65
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
“…germline SDHC (PGL3) mutations were reported to cause familial HNPGL (inherited as an autosomal dominant trait without parentof-origin effects) (Niemann & Muller 2000) and germline SDHB (PGL4) mutations were found to cause inherited susceptibility to HNPGL and pheochromocytomas and…”
BackgroundGermline and mosaic mutations causing pituitary tumours: genetic and molecular aspects
Pepe, S., Korbonits, M., & Iacovazzo, D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0446 · Cited by 64
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Bayley, J., Oldenburg, R. A., Nuk, J., Hoekstra, A. S., van der Meer, C. A., Korpershoek, E., McGillivray, B., Corssmit, E. P. M., Dinjens, W. N. M., de Krijger, R. R., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0111-8 · Cited by 63
“1p36) [5], SDHC (chromosome 1q23) [6], SDHAF2 (chromosome 11q12.”
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands
Hensen, E. F., van Duinen, N., Jansen, J. C., Corssmit, E. P. M., Tops, C., Romijn, J. A., Vriends, A. H. J. T., van der Mey, A., Cornelisse, C., Devilee, P., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01653.x · Cited by 63
New Insights into the Genetics of Familial Chromaffin Cell Tumors
Koch, C. A., Vortmeyer, A. O., Zhuang, Z., Brouwers, F. M., & Pacák, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04409.x · Cited by 63
Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmesz, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.38.ja3 · Cited by 62
Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases
Moreno, C., Santos, R. M., Burns, R., & Zhang, W. C. (2020) · Cancers · doi:10.3390/cancers12113237 · Cited by 62
“Mutations in SDHB [29], SDHC [30], and SDHD [31] have been implicated in causing two rare tumors in the autonomic nervous system known as paraganglioma (PGL) and pheochromocytoma (PCC) [32].”
BackgroundSdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma
Bayley, J.-P., van Minderhout, I., Hogendoorn, P. C. W., Cornelisse, C. J., van der Wal, A., Prins, F. A., Teppema, L., Dahan, A., Devilee, P., & Taschner, P. E. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007987 · Cited by 53
“Subsequently, two other subunits of SDH, SDHC (chromosome 1q21) [2], and SDHB (chromosome”
BackgroundGamma Knife radiosurgery for glomus jugulare tumors: a single-center series of 75 cases
Ibrahim, R., Ammori, M. B., Yianni, J., Grainger, A., Rowe, J. G., & Radatz, M. W. R. (2016) · Journal of neurosurgery · doi:10.3171/2016.4.jns152667 · Cited by 61
Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy (Review)
Čtvrtlík, F., Koranda, P., Schovánek, J., Škarda, J., Hartmann, I., & Tüdös, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5871 · Cited by 62
“Furthermore, familial paraganglioma syndromes are associated with mutations in genetic encoding for the enzyme succinate dehydrogenase subunits A, B, C, and D (SDHA, SDHB, SDHC, and SDHD) (14-17).”
BackgroundCarney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency
Pitsava, G., Settas, N., Faucz, F. R., & Stratakis, C. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.680609 · Cited by 61
Parasympathetic Paragangliomas Are Part of the Von Hippel-Lindau Syndrome
Gaal, J., van Nederveen, F. H., Erlic, Z., Korpershoek, E., Oldenburg, R. A., Boedeker, C. C., Kontny, U., Neumann, H. P. H., Dinjens, W. N. M., & de Krijger, R. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1479 · Cited by 60
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 60
Gaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 61
Selak, M. A., Durán, R. V., & Gottlieb, E. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.05.015 · Cited by 59
Diagnosis and management of pheochromocytoma
Hodin, R. A., Lubitz, C. C., Phitayakorn, R., & Stephen, A. E. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.12.001 · Cited by 59
“Familial PGL refers to a syndrome in which patients are predisposed to developing PGLs throughout the body, which may or may not produce catecholamines.(23) This genetic syndrome, also autosomal dominant, is most frequently”
BackgroundPhenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II
Pagnamenta, A. T., Hargreaves, I. P., Duncan, A. J., Taanman, J., Heales, S., Land, J. M., Bitner-Glindzicz, M. A. K., Leonard, J. V., & Rahman, S. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.003 · Cited by 59
Mitochondrial diseases: a nosological update
Filosto, M., & Mancuso, M. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00777.x · Cited by 59
Mitochondrial disorders: Clinical presentation and diagnostic dilemmas
Smeitink, J. A. M. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024489218004 · Cited by 52
“…a disorder characterized by the presence of benign, highly vascularized tumours of parasympatic ganglia in the head and neck, most commonly occurring in the carotid body (Baysal 2000; Niemann and Mˇller 2000), illustrates the clinical diversity associated with mitochondrial pathology.”
BackgroundSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 58
“SDHC. SDHCmutations leading to head and neck PGLs were first described by Niemann and Muller [80].”
BackgroundHensen, E. F., Siemers, M., Jansen, J. C., Corssmit, E. P. M., Romijn, J. A., Tops, C. M. J., van der Mey, A. G. L., Devilee, P., Cornelisse, C. J., Bayley, J., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04097.x · Cited by 58
Protein lysine acetylation guards metabolic homeostasis to fight against cancer
Xu, W., Li, Y., LIU, C., & Zhao, S. (2013) · Oncogene · doi:10.1038/onc.2013.163 · Cited by 58
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
Foo, B. J.-A., Eu, J. Q., Hirpara, J. L., & Pervaiz, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1341604 · Cited by 58
Genetic basis of phaeochromocytoma and paraganglioma
Benn, D. E., & Robinson, B. G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.005 · Cited by 58
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential
Wagner, A., Kosnacova, H., Chovanec, M., & Jurkovičová, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147897 · Cited by 57
Dixon, J. L., Atkins, M. D., Bohannon, W. T., Buckley, C. J., & Lairmore, T. C. (2016) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2016.11929343 · Cited by 57
Metabolic Rewiring and the Characterization of Oncometabolites
Beyoğlu, D., & Idle, J. R. (2021) · Cancers · doi:10.3390/cancers13122900 · Cited by 57
“Concurrently, SDHC mutations were shown to be a cause of autosomal dominant paraganglioma type 3 [54].”
BackgroundYang, C., Harrison, C., Jin, E. S., Chuang, D. T., Sherry, A. D., Malloy, C. R., Merritt, M. E., & DeBerardinis, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543637 · Cited by 51
Casey, R. T., Ascher, D. B., Rattenberry, E., Izatt, L., Andrews, K. A., Simpson, H. L., Challis, B., Park, S., Bulusu, V. R., Lalloo, F., et al. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.279 · Cited by 51
“One patient with a sympathetic bladder PGL and a c.91C>T (p.Arg31*) variant (Burnichon et al. 2012), and a second patient with a HNPGL and a c.1534C>T (p.Arg512*) variant (Papathomas et al. 2015).”
BackgroundBandara, A. B., Drake, J. C., & Brown, D. A. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00370-w · Cited by 56
Genetic Basis of Cancer of the Kidney
Sudarshan, S., & Linehan, W. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.008 · Cited by 56
Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O'Neill, C. F., Parekh, D. J., Yeh, I.-T., Sun, L.-Z., & Block, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 52
“Multiple other genes encoding enzymes of the tricarboxylic (TCA) cycle are considered tumor suppressor genes including SDHB, SDHC, and SDHD (Succinate Dehydrogenase subunits B,C,D) [32,33,34].”
BackgroundLima, J., Feijão, T., Ferreira da Silva, A., Pereira-Castro, I., Fernandez-Ballester, G., Máximo, V., Herrero, A., Serrano, L., Sobrinho-Simões, M., & Garcia-Rostan, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0640 · Cited by 54
Mitochondrial diseases and the role of the yeast models
Rinaldi, T., Dallabona, C., Ferrero, I., Frontali, L., & Bolotin‐Fukuhara, M. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00685.x · Cited by 54
Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells
Hart, M. L., Quon, E., Vigil, A.-L. B. G., Engström, I., Newsom, O. J., Davidsen, K., Hoellerbauer, P., Carlisle, S. M., & Sullivan, L. B. (2023) · eLife · doi:10.7554/elife.78654 · Cited by 54
“…loss- of- function mutations to the subunits of SDH (A- D) or SDH assembly factors (SDHAF1- 2), can lead to neoplasms in neuroendocrine tissues and the kidney (Astuti et al., 2001; Bardella et al., 2011; Baysal et al., 2000; Burnichon et al., 2010; Hao et al., 2009; Niemann and Müller, 2000).”
Jose, C., Melser, S., Benard, G., & Rossignol, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 46
“…the mitochondrial energy proteins succinate dehydrogenase (SDH), fumarate hydratase (FH), and isocitrate dehydrogenase (IDH) in cancer susceptibility (56, 57, 96, 140, 191, 291), the above-described experiments with rotenone might suggest that mitochondrial impairment could favor cancer initiation.”
Lemarié, A., & Grimm, S. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.03.004 · Cited by 53
“This and the recent findings linking complex II mutations to Hypoxia InducibleFactor-1 could explain, amongst others, why some of its subunits have been proposed to constitute tumour suppressors in a range of different cancers (Baysal et al., 2000; Gottlieb and Tomlinson, 2005; Niemann and Muller, 2000; Selak et al.,…”
BackgroundGhayee, H. K., Havekes, B., Corssmit, E. P. M., Eisenhofer, G., Hammes, S. R., Ahmad, Z., Tessnow, A. H., Lazúrová, I., Adams, K. T., Fojo, A. T., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0214 · Cited by 53
“By contrast, mutations in the genes encoding succinate dehydrogenase (SDH) subunits B, C, and D cause extra-adrenal PGLs associated with familial PGL syndromes PGL4, PGL3, and PGL1 respectively (Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001).”
BackgroundAldera, A. P., & Govender, D. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204677 · Cited by 54
Genetic and epigenetic profile of sporadic pheochromocytomas
Cascón, A., Ruiz-Llorente, S., Fraga, M. F., Leton, R., Telleria, D., Sastre, J., Diez, J. J., Diaz-Guerra, G. M., Perez, J. A. D., Benitez, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.012658 · Cited by 53
The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now
Tischler, A. S., Pacák, K., & Eisenhofer, G. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9286-3 · Cited by 52
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
Pang, Y. K., Liu, Y., Pacák, K., & Yang, C. (2019) · Cancers · doi:10.3390/cancers11040436 · Cited by 52
“In 2000, SDHC and SDHD were first identified as susceptibility genes for hereditary PCPGs [13,14].”
BackgroundEscherichia coli succinate dehydrogenase variant lacking the heme b
Tran, Q. M., Rothery, R. A., Maklashina, E., Cecchini, G., & Weiner, J. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707732104 · Cited by 51
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Zhao, Y., Feng, F., Guo, Q., Wang, Y., & Zhao, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5074 · Cited by 52
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge
Gimm, O., DeMicco, C., Perren, A. A., Giammarile, F., Walz, M. K., & Brunaud, L. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0880-x · Cited by 51
Cancer morphogenesis: role of mitochondrial failure.
Fosslien, E. (2008) · PubMed · Cited by 51
Simi, L., Sestini, R., Ferruzzi, P., Gaglianò, M. S., Gensini, F., Mascalchi, M., Guerrini, L., Pratesi, C., Pinzani, P., Nesi, G., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030353 · Cited by 51
Germline SDHD mutation in paraganglioma of the spinal cord
Masuoka, J., Brandner, S., Paulus, W., Soffer, D., Vital, A., Chimelli, L. M. C., Jouvet, A., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204579 · Cited by 51
“Recent analyses by Niemann and Muller (2000) demonstrated a germline mutation in the SDHC gene on this locus in patients from a family with the non-maternally imprinted hereditary paragangliomas.”
BackgroundAnimal Mitochondria: Evolution, Function, and Disease
Tao, M., You, C., Zhao, R., Liu, S., Zhang, Z., Zhang, C., & Liu, Y. (2013) · Current Molecular Medicine · doi:10.2174/15665240113136660081 · Cited by 50
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 50
“The SDH complex gene-associated cancers include paragangliomas, pheochromocytomas, gastrointestinal stromal tumors (GIST), SDH-deficient renal cell carcinoma [54,55], thyroid tumors, neuroblastomas, testicular seminoma, and ovarian cancer [56].”
BackgroundMapping of a novel MEN-like syndrome locus to rat Chromosome 4
Piotrowska, K., Pellegata, N. S., Rosemann, M., Fritz, A., Graw, J., & Atkinson, M. J. (2004) · Mammalian Genome · doi:10.1007/s00335-003-3027-8 · Cited by 50
“…involved in hereditary phaechromocytomas (Crossey et al. 1995; Woodward et al. 1997; Astuti et al. 2001) and paragangliomas (Baysal et al. 2000; Niemann and Muller 2000) have been recently isolated; however, they account for only a small fraction of the sporadic tumor cases (reviewed in Maher…”
BackgroundReversible regulation of metastasis by ROS-generating mtDNA mutations
Ishikawa, K., Koshikawa, N., Takenaga, K., Nakada, K., & Hayashi, J. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.07.006 · Cited by 50
Strosberg, J. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.11.009 · Cited by 49
Pheochromocytoma and paraganglioma: molecular testing and personalized medicine
Burnichon, N., Buffet, A., & Gimenez‐Roqueplo, A. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000249 · Cited by 49
Charville, G. W., & Longacre, T. A. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000166 · Cited by 49
A Guide to Pheochromocytomas and Paragangliomas
Guilmette, J. M., & Sadow, P. M. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.08.009 · Cited by 49
Zhang, X., Dong, W., Zhang, J., Liu, W., Yin, J., Shi, D., & Ma, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740487 · Cited by 49
“…ROS outbreak, which mediates epithelialmesenchymal transition and cell invasion in lung cancer via coordinate intracellular signal transduction (Nunes et al., 2015; He et al., 2016; Han et al., 2018). mtDNA variations have been frequently suggested to serve as initiators for a variety of…”
BackgroundZantour, B., Guilhaume, B., Tissier, F., Louvel, A., Jeunemaître, X., Gimenez‐Roqueplo, A., & BERTAGNA, X. Y. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510433 · Cited by 49
Toledo, R. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0479 · Cited by 48
The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors
Xekouki, P., Brennand, A., Whitelaw, B., Pacák, K., & Stratakis, C. A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0661-0341 · Cited by 50
Lee, H., Jeong, S., Yu, Y., Kang, J., Sun, H., Rhee, J., & Kim, Y. H. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106324 · Cited by 48
Metabolic Drivers in Hereditary Cancer Syndromes
Sciacovelli, M., Schmidt, C., Maher, E. R., & Frezza, C. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033612 · Cited by 48
“…a century ago (Warburg 1924), the first metabolic drivers of tumorigenesis were identified only 20 years ago, when it was shown that mutations in SDH subunit genes (SDHX) (Astuti et al. 2001b, Baysal et al. 2000, Niemann & Müller 2000) and FH (Tomlinson et al. 2002) predispose to familial cancers.”
BackgroundThe Genetic Basis of Pheochromocytoma and Paraganglioma: Implications for Management
Shuch, B. M., Ricketts, C. J., Metwalli, A. R., Pacák, K., & Linehan, W. M. (2014) · Urology · doi:10.1016/j.urology.2014.01.007 · Cited by 47
Minireview: The Busy Road to Pheochromocytomas and Paragangliomas Has a New Member, TMEM127
Jiang, S., & Dahia, P. L. M. (2011) · Endocrinology · doi:10.1210/en.2011-0052 · Cited by 47
“SDHB SDH, mitochondria respiratory chain; tricyclic acid cycle Tumor suppressor gene Carney-Stratakis syndrome Paraganglioma (sympathetic and parasympathetic); gastrointestinal stromal tumors SDHB/ SDHC/SDHD SDH, mitochondria respiratory chain; tricyclic acid cycle Tumor suppressor gene Neurofibromatosis type 1 Neurof…”
BackgroundInfluentialGuo, Y., Wei, X., Das, J., Grimson, A., Lipkin, S. M., Clark, A. G., & Yu, H. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.022 · Cited by 47
Rustin, P., & Kroemer, G. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_086 · Cited by 47
Genetics of familial paragangliomas
Baysal, B. E. (2001) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70352-2 · Cited by 47
Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors
Baysal, B. E. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.005 · Cited by 46
“In contrast, abundant data show that penetrance of SDHB and SDHCmutations are not low [2,21].”
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum?
Herrera-Cruz, M. S., & Simmen, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00105 · Cited by 47
“Moreover, mutations in nuclear-encoded succinate dehydrogenase can by themselves cause paraganglioma (32, 33), potentially from increased ROS production within mitochondria that leads to oxidative damage and eventually transformation (34).”
BackgroundEnhanced glycolysis induced by mtDNA mutations does not regulate metastasis
Ishikawa, K., Hashizume, O., Koshikawa, N., Fukuda, S., Nakada, K., Takenaga, K., & Hayashi, J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.09.024 · Cited by 46
Arnold, S., Strecker, R., Scheffler, K., Spreer, J., Schipper, J. H., Neumann, H. P. H., & Klisch, J. (2002) · European Radiology · doi:10.1007/s00330-002-1717-3 · Cited by 46
“focus in families with inherited paragangliomas or glomus tumors has been identified [2, 3].”
BackgroundPathogenic mutations of nuclear genes associated with mitochondrial disorders
Zhu, X., Peng, X.-R., Guan, M., & Yan, Q. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmn021 · Cited by 46
Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD
Dannenberg, H., van Nederveen, F. H., Abbou, M., Verhofstad, A. A. J., Komminoth, P., de Krijger, R. R., & Dinjens, W. N. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.198 · Cited by 46
SDHC mutations in hereditary paraganglioma/pheochromocytoma
Müller, U., Troidl, C., & Niemann, S. (2005) · Familial Cancer · doi:10.1007/s10689-004-0621-1 · Cited by 46
“Histological section of a paraganglioma from an affected member of the original PGL3 family [4].”
BackgroundSelf-citationKaipparettu, B. A., Ma, Y., & Wong, L. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05621.x · Cited by 45
Nölting, S., García, E., Alusi, G., Giubellino, A., Pacák, K., Korbonits, M., & Grossman, A. B. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0028 · Cited by 45
“…follow two separate routes to tumourigenesis, clusters 1 and 2 (Viskochil et al. 1990, Latif et al. 1993, Mulligan et al. 1993, Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2003, Eisenhofer et al. 2004, Dahia et al. 2005a,b, Powers et al. 2007, Ladroue et al. 2008, Schlisio et al.…”
BackgroundEpigenetic and metabolic reprogramming of SDH-deficient paragangliomas
Moog, S., Lussey‐Lepoutre, C., & Favier, J. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0346 · Cited by 45
“The mitochondrial-specific granular staining is lost in tumor cells for all subtypes of SDHx mutations (SDHA, SDHB, SDHC, SDHD and SDHAF2) while it is maintained in stromal cells such as endothelial cells, adipocytes or sustentacular cells, providing internal positive controls (van Nederveen et al.”
MethodInfluentialA novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma
Cascón, A., Ruiz‐Llorente, S., Rodríguez, S., Honrado, E., Martínez‐Ramírez, Á., Letón, R., Montero‐Conde, C., Benitez, J. J., Dopazo, J., Cigudosa, J. C., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20139 · Cited by 45
“…and PCCs occur sporadically, although about 25% of PCCs and an uncertain percentage of PGLs may be associated with hereditary syndromes (Schimke, 1990; Anderson and Lynch, 1993; Maher et al., 1996; Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001; Carney and Stratakis, 2002).”
BackgroundBezawork‐Geleta, A., Saiyed, T., Dougan, D. A., & Truscott, K. N. (2014) · The FASEB Journal · doi:10.1096/fj.13-242420 · Cited by 44
Crona, J., Nordling, M., Maharjan, R., Granberg, D. O., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086756 · Cited by 44
“Translational studies show that approximately 60% of PCC and PGL cases have either germline or somatic mutations in one of 13 suggested disease causing loci; SDH subunits A, B, C and D, SDHAF2, VHL, EPAS1, RET, NF1, TMEM127, MAX and H-RAS [8–20].”
BackgroundSDHC mutation in an elderly patient without familial antecedents
López-Jiménez, E. A., de Campos, J. M., Kusak, E., Landa, I., Leskelä, S., Montero‐Conde, C., Leandro-Garcia, L. J., Vallejo, L. A., Madrigal, B., Rodríguez‐Antona, C., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03368.x · Cited by 44
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 45
Familial paraganglioma syndromes: Table 1
Chetty, R. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.076257 · Cited by 44
“These patients may also be at risk for the development of renal cell cancer and papillary thyroid cancer.(13) 6.”
BackgroundThe genetics of paragangliomas
Burnichon, N., Abermil, N., Buffet, A., Favier, J., & Gimenez‐Roqueplo, A. (2012) · European Annals of Otorhinolaryngology Head and Neck Diseases · doi:10.1016/j.anorl.2012.04.007 · Cited by 43
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
Taïeb, D., & Pacák, K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.08.001 · Cited by 43
“%) compared to SDHA, SDHC, and SDHD PPGLs (where occurrence of metastatic disease is rare, 0–4”
Renard, L., Godfraind, C., Boon, L. M., & Vikkula, M. (2003) · Head & Neck · doi:10.1002/hed.10220 · Cited by 38
Ishii, T., Miyazawa, M., Onodera, A., Yasuda, K., Kawabe, N., Kirinashizawa, M., Yoshimura, S., Maruyama, N., Hartman, P. S., & Ishii, N. (2011) · Mitochondrion · doi:10.1016/j.mito.2010.09.006 · Cited by 42
“PGL1, PGL3, and PGL4 have been associated with germline mutations in the SDHB, SDHC, and SDHD subunits of SDH (Astuti et al., 2001; Niemann and Muller, 2000; Baysal et al., 2000).”
BackgroundRichter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Backman, S., Maharjan, R., Falk-Delgado, A., Crona, J., Cupisti, K., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2017) · Scientific Reports · doi:10.1038/srep44943 · Cited by 42
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Increased gene dosage of myelin protein zero causes Charcot‐Marie‐Tooth disease
Maeda, M. H., Mitsui, J., Soong, B., Takahashi, Y., Ishiura, H., Hayashi, S., Shirota, Y., Ichikawa, Y., Matsumoto, H., Arai, M., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22658 · Cited by 42
Powerhouse down: Complex II dissociation in the respiratory chain
Hwang, M., Rohlena, J., Dong, L., Neužil, J., & Grimm, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.001 · Cited by 42
Panizza, E., Ercolino, T., Mori, L., Rapizzi, E., Castellano, M., Opocher, G., Ferrero, I., Neumann, H. P. H., Mannelli, M., & Goffrini, P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds487 · Cited by 42
Bailey, P. S. J., & Nathan, J. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020060 · Cited by 41
“As previously discussed, somatic and germline mutations of SDH subunits are commonly identified in patients with paraganglioma [22,106,107], where the accumulation of succinate inhibits HIF prolyl hydroxylation, driving the expression of HIF target genes [30].”
BackgroundRenal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 41
Screening for familial paragangliomas
Myssiorek, D. J., Ferlito, A., Silver, C. E., Rodrigo, J. P., Baysal, B. E., Fagan, J. J., Suarez, C. M., & Rinaldo, A. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.010 · Cited by 41
Outcomes after Surgical Resection of Head and Neck Paragangliomas: A Review of 61 Patients
Neskey, D. M., Hatoum, G. F., Modh, R. A., Civantos, F., Telischi, F. F., Angeli, S. I., Weed, D. T., & Sargi, Z. (2011) · Skull base · doi:10.1055/s-0031-1275251 · Cited by 41
“Between 10% and 50% of paragangliomas are familial with 10% of cases inherited through germ line mutations in mitochondrial complex II genes.(5,6) Additionally, these tumors can be multicentric, which occurs in 10 to 20% of sporadic cases and up to 80% of familial cases of VPs in a series by Netterville et al.”
BackgroundAn iron regulatory-like protein expressed in Plasmodium falciparum displays aconitase activity
Hodges, M. G., Yikilmaz, E., Patterson, G. H., Kasvosve, I., Rouault, T. A., Gordeuk, V. R., & Loyevsky, M. (2005) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.05.004 · Cited by 41
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.